Manulife (Manufacturers Life Insurance)
BDTX icon

Manulife (Manufacturers Life Insurance)’s Black Diamond Therapeutics BDTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,062
Closed -$15.6K – 2912
2025
Q1 		$15.6K Buy
+10,062
New +$21.1K ﹤0.01% 2887
2024
Q4 		– Sell
-59,507
Closed -$259K – 2977
2024
Q3 		$259K Sell
59,507
-682
-1% -$3.71K ﹤0.01% 2550
2024
Q2 		$280K Buy
+60,189
New +$323K ﹤0.01% 2449
2021
Q3 		– Sell
-14,876
Closed -$181K – 3152
2021
Q2 		$181K Buy
14,876
+3,881
+35% +$76.7K ﹤0.01% 3154
2021
Q1 		$267K Buy
10,995
+35
+0.3% +$944 ﹤0.01% 2686
2020
Q4 		$351K Buy
10,960
+929
+9% +$30.5K ﹤0.01% 2411
2020
Q3 		$303K Buy
10,031
+2,951
+42% +$89.8K ﹤0.01% 2291
2020
Q2 		$282K Buy
+7,080
New +$261K ﹤0.01% 2297

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BDTX Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Black Diamond Therapeutics (BDTX) in Q2 2025, closing a stake of 10,062 shares — an estimated $15.6K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BDTX in Q2 2020 and held it in 8 quarters. The position peaked at $351K in Q4 2020. 94 funds tracked by Wall St. Rank hold BDTX as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Black Diamond Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,062 Black Diamond Therapeutics shares in Q2 2025, an estimated $15.6K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Black Diamond Therapeutics in Q2 2020 and held it in 8 quarters.
  • Manulife (Manufacturers Life Insurance)'s Black Diamond Therapeutics position peaked at $351K in Q4 2020.
  • 94 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.